ENTELLUS MED INC's ticker is ENTL and the CUSIP is 29363K105. A total of 73 filers reported holding ENTELLUS MED INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $16,363,000 | +40.1% | 670,904 | +6.0% | 4.49% | +21.3% |
| Q3 2017 | $11,680,000 | +37.6% | 632,737 | +23.5% | 3.70% | +29.9% |
| Q2 2017 | $8,486,000 | +50.9% | 512,416 | +25.7% | 2.85% | +32.6% |
| Q1 2017 | $5,623,000 | -24.2% | 407,497 | +4.1% | 2.15% | -34.2% |
| Q4 2016 | $7,423,000 | -14.4% | 391,289 | +0.0% | 3.26% | -12.7% |
| Q3 2016 | $8,676,000 | +19.8% | 391,169 | -1.3% | 3.74% | +11.4% |
| Q2 2016 | $7,240,000 | +0.2% | 396,291 | -0.2% | 3.35% | -8.0% |
| Q1 2016 | $7,224,000 | +9.4% | 397,141 | +1.4% | 3.64% | +31.8% |
| Q4 2015 | $6,601,000 | +51.1% | 391,497 | +61.4% | 2.76% | +28.1% |
| Q3 2015 | $4,370,000 | – | 242,532 | – | 2.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,956,456 | $48,960,000 | 52.70% |
| Discovery Group I, LLC | 2,169,729 | $35,931,000 | 10.38% |
| Essex Woodlands Management, Inc. | 3,231,656 | $53,516,000 | 9.68% |
| Archon Capital Management LLC | 478,820 | $7,929,000 | 6.46% |
| First Light Asset Management, LLC | 512,416 | $8,486,000 | 2.85% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 341,468 | $5,655,000 | 2.15% |
| Ghost Tree Capital, LLC | 375,000 | $6,210,000 | 1.29% |
| PERKINS CAPITAL MANAGEMENT INC | 68,316 | $1,131,000 | 1.25% |
| Cypress Capital Management LLC (WY) | 63,540 | $1,052,222,000 | 1.21% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 35,000 | $580,000 | 0.66% |